283 related articles for article (PubMed ID: 27126205)
1. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.
Alsaleh A; Gaidos JK; Kang L; Kuemmerle JF
Dig Dis Sci; 2016 Sep; 61(9):2602-7. PubMed ID: 27126205
[TBL] [Abstract][Full Text] [Related]
2. Effects of preoperative anti-tumour necrosis factor alpha infusion timing on postoperative surgical site infection in inflammatory bowel disease: A systematic review and meta-analysis.
Qiu Y; Zheng Z; Liu G; Zhao X; He A
United European Gastroenterol J; 2019 Nov; 7(9):1198-1214. PubMed ID: 31700633
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
Kotze PG; Saab MP; Saab B; da Silva Kotze LM; Olandoski M; Pinheiro LV; Martinez CA; Ayrizono ML; Magro DO; Coy CS
Dig Dis Sci; 2017 Feb; 62(2):456-464. PubMed ID: 27933472
[TBL] [Abstract][Full Text] [Related]
4. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications.
Kunitake H; Hodin R; Shellito PC; Sands BE; Korzenik J; Bordeianou L
J Gastrointest Surg; 2008 Oct; 12(10):1730-6; discussion 1736-7. PubMed ID: 18709514
[TBL] [Abstract][Full Text] [Related]
5. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.
Schaufler C; Lerer T; Campbell B; Weiss R; Cohen J; Sayej W; Hyams J
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):421-4. PubMed ID: 22395189
[TBL] [Abstract][Full Text] [Related]
6. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem.
Brady MT; Patts GJ; Rosen A; Kasotakis G; Siracuse JJ; Sachs T; Kuhnen A; Kunitake H
Dis Colon Rectum; 2017 Jan; 60(1):61-67. PubMed ID: 27926558
[TBL] [Abstract][Full Text] [Related]
8. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
[TBL] [Abstract][Full Text] [Related]
9. The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease.
Nguyen GC; Elnahas A; Jackson TD
J Crohns Colitis; 2014 Dec; 8(12):1661-7. PubMed ID: 25107847
[TBL] [Abstract][Full Text] [Related]
10. A national survey on the patterns of treatment of inflammatory bowel disease in Canada.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168
[TBL] [Abstract][Full Text] [Related]
11. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.
Lightner AL; Raffals LE; Mathis KL; Cima RR; Tse CS; Pemberton JH; Dozois EJ; Loftus EV
J Crohns Colitis; 2017 Feb; 11(2):185-190. PubMed ID: 27543504
[TBL] [Abstract][Full Text] [Related]
12. Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience.
Shwaartz C; Fields AC; Sobrero M; Cohen BD; Divino CM
J Gastrointest Surg; 2016 Sep; 20(9):1636-42. PubMed ID: 27405310
[TBL] [Abstract][Full Text] [Related]
13. Benefit of Earlier Anti-TNF Treatment on IBD Disease Complications?
Nuij V; Fuhler GM; Edel AJ; Ouwendijk RJ; Rijk MC; Beukers R; Quispel R; van Tilburg AJ; Tang TJ; Smalbraak H; Bruin KF; Lindenburg F; Peyrin-Biroulet L; van der Woude CJ;
J Crohns Colitis; 2015 Nov; 9(11):997-1003. PubMed ID: 26223842
[TBL] [Abstract][Full Text] [Related]
14. Preoperative infliximab therapy does not increase morbidity and mortality after laparoscopic resection for inflammatory bowel disease.
Krane MK; Allaix ME; Zoccali M; Umanskiy K; Rubin MA; Villa A; Hurst RD; Fichera A
Dis Colon Rectum; 2013 Apr; 56(4):449-57. PubMed ID: 23478612
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis.
Yang Z; Wu Q; Wu K; Fan D
Aliment Pharmacol Ther; 2010 Feb; 31(4):486-92. PubMed ID: 19925496
[TBL] [Abstract][Full Text] [Related]
16. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
Rosenfeld G; Qian H; Bressler B
J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Biologics on Postoperative Complications in Children With Inflammatory Bowel Disease and Bowel Resection.
Mitsuya JB; Gonzalez R; Thomas R; El-Baba M
J Pediatr Gastroenterol Nutr; 2019 Mar; 68(3):334-338. PubMed ID: 30247424
[TBL] [Abstract][Full Text] [Related]
18. A Practical Predictive Index for Intra-abdominal Septic Complications After Primary Anastomosis for Crohn's Disease: Change in C-Reactive Protein Level Before Surgery.
Zuo L; Li Y; Wang H; Zhu W; Zhang W; Gong J; Li N; Li J
Dis Colon Rectum; 2015 Aug; 58(8):775-81. PubMed ID: 26163957
[TBL] [Abstract][Full Text] [Related]
19. The burden of surgery and postoperative complications in children with inflammatory bowel disease.
Fehmel E; Teague WJ; Simpson D; McLeod E; Hutson JM; Rosenbaum J; Oliver M; Alex G; King SK
J Pediatr Surg; 2018 Dec; 53(12):2440-2443. PubMed ID: 30244938
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients.
Lightner AL; McKenna NP; Alsughayer A; Loftus EV; Raffals LE; Faubion WA; Moir C
J Pediatr Surg; 2019 Oct; 54(10):2162-2165. PubMed ID: 30773391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
